From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.
Researchers at University of California San Diego School of Medicine are recruiting eligible children between the ages of seven and fourteen years for a Phase III clinical trial to determine whether cannabidiol (CBD) reduces severe behavior problems in children with autism spectrum disorder.
By inhibiting the molecule AKT, UC San Diego researchers favor the culture of human spermatogonial stem cells in the lab, a first step toward lab-produced sperm as a treatment for male infertility.
Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.
Researchers at the University of New Hampshire and elsewhere used SDSC's Comet supercomputer to validate a model using a machine learning technique called Dynamic Time Lag Regression (DTLR) to help predict the arrival of solar winds near the Earth’s orbit from physical parameters of the Sun.
With help from technology developed by UC San Diego researchers at the Qualcomm Institute, a team of underwater cave explorers in Mexico have made unprecedented archaeological discoveries in some of the most inaccessible places on Earth about the earliest inhabitants of the Western Hemisphere.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
